Your browser doesn't support javascript.
loading
International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis.
Johansen, Karin U; Augustinus, Simone; Wellner, Ulrich F; Andersson, Bodil; Beane, Joal D; Björnsson, Bergthor; Busch, Olivier R; Davis, Catherine H; Ghadimi, Michael; Gleeson, Elizabeth M; de Graaf, Nine; Koerkamp, Bas Groot; Pitt, Henry A; van Santvoort, Hjalmar C; Tingstedt, Bobby; Uhl, Waldemar; Werner, Jens; Williamsson, Caroline; Besselink, Marc G; Keck, Tobias.
Afiliação
  • Johansen KU; Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Sweden.
  • Augustinus S; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.
  • Wellner UF; DGAV StuDoQ|Pancreas Registry and Clinic of Surgery, UKSH Campus Lübeck, Germany.
  • Andersson B; Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.
  • Beane JD; Department of Surgery, The Ohio State University, Columbus, USA.
  • Björnsson B; Department of Surgery in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Sweden.
  • Busch OR; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.
  • Davis CH; Department of Surgery, Baylor University Medical Center, Dallas, TX.
  • Ghadimi M; Department of General, Visceral, and Paediatric Surgery, University Medical Centre Göttingen, Germany.
  • Gleeson EM; Department of Surgery, University of North Carolina at Chapel Hill, USA.
  • de Graaf N; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.
  • Koerkamp BG; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Pitt HA; Rutgers Cancer Institute of New Jersey, New Brunswick, USA.
  • van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht and St. Antonius Hospital Nieuwegein, the Netherlands.
  • Tingstedt B; Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.
  • Uhl W; Klinik für Allgemein- und Viszeralchirurgie, St. Josef-Hospital Bochum, Klinik der Ruhr-Universität, Bochum.
  • Werner J; Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Ludwig-Maximilians-Universität, München.
  • Williamsson C; Department of Clinical Sciences Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden.
  • Besselink MG; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.
  • Keck T; DGAV StuDoQ|Pancreas Registry and Clinic of Surgery, UKSH Campus Lübeck, Germany. Electronic address: tobias.keck@uksh.de.
Surgery ; 2024 Jul 16.
Article em En | MEDLINE | ID: mdl-39019733
ABSTRACT

BACKGROUND:

The efficacy and safety of minimally invasive distal pancreatectomy have been confirmed by randomized trials, but current patient selection and outcome of minimally invasive distal pancreatectomy in large international cohorts is unknown. This study aimed to compare the use and outcome of minimally invasive distal pancreatectomy in North America, the Netherlands, Germany, and Sweden.

METHODS:

All patients in the 4 Global Audits on Pancreatic Surgery Group (GAPASURG) registries who underwent minimally invasive distal pancreatectomy or open distal pancreatectomy during 2014-2020 were included.

RESULTS:

Overall, 20,158 distal pancreatectomies were included, of which 7,316 (36%) were minimally invasive distal pancreatectomies. Use of minimally invasive distal pancreatectomy varied from 29% to 54% among registries, of which 13% to 35% were performed robotically. Both the use of minimally invasive distal pancreatectomy and robotic surgery were the highest in the Netherlands. Patients undergoing minimally invasive distal pancreatectomy tended to have a younger age (Germany and Sweden), female sex (North America, Germany), higher body mass index (North America, the Netherlands, Germany), lower comorbidity classification (North America, Germany, Sweden), lower performance status (Germany), and lower rate of pancreatic adenocarcinoma (all). The minimally invasive distal pancreatectomy group had fewer vascular resections (all) and lower rates of severe complications and mortality (North America, Germany). In the multivariable regression analysis, country was associated with severe complications but not with 30-day mortality. Minimally invasive distal pancreatectomy was associated with a lower risk of 30-day mortality compared with open distal pancreatectomy (odds ratio 1.633, 95% CI 1.159-2.300, P = .005).

CONCLUSIONS:

Considerable disparities were seen in the use of minimally invasive distal pancreatectomy among 4 transatlantic registries of pancreatic surgery. Overall, minimally invasive distal pancreatectomy was associated with decreased mortality as compared with open distal pancreatectomy. Differences in patient selection among countries could imply that countries are in different stages of the learning curve.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Surgery Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Surgery Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia